Author:
Dodiya Hardik,Patel Amit,Patel Dipal,Kaushal Ashish,Vijay D. G.
Publisher
Springer Science and Business Media LLC
Reference36 articles.
1. Horita K, Yamaguchi A, Hirose K, Ishida M, Noriki S, Imamura Y, et al. Prognostic factors affecting disease-free survival rate following surgical resection of primary breast cancer. Eur J Histochem. 2001;45(1):73–84.
2. Thor AD, Berry DA, Budman DR, Muss HB, Kute T, Henderson IC, et al. Cerb B2 expression, p53 and efficacy of adjuvant therapy in lymph node positive breast cancer. J Nat Cancer Inst. 1998;90:1346–60.
3. Thor AD, Jeruss JS. Prognostic and predictive markers in breast cancer. In: Bonadonna G, Hortobagyi GN, Gianni AM, editors. Textbook of breast cancer a clinical guide to therapy. 2nd ed. London: Martin Dunitz; 2001. p. 63–84.
4. Paik S, Kim C, Wolmark N. Her2 status and benefit from adjuvant transtuzumab in breast cancer. New Engl J Med. 2008;358(13):1409–11.
5. Leake R, Barnes D, Pinder S, Anderson L, Anderson T, Adampson R, et al. Immunohistochemical detection of steroid receptor in breast cancer. J Clin Pathol. 2000;53:634–5.
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献